Huaxia Eye Hospital Group Co. Ltd. A
Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular … Read more
Huaxia Eye Hospital Group Co. Ltd. A (301267) - Net Assets
Latest net assets as of June 2025: CN¥6.06 Billion CNY
Based on the latest financial reports, Huaxia Eye Hospital Group Co. Ltd. A (301267) has net assets worth CN¥6.06 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.17 Billion) and total liabilities (CN¥2.11 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥6.06 Billion |
| % of Total Assets | 74.23% |
| Annual Growth Rate | 42.73% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 70.93 |
Huaxia Eye Hospital Group Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how Huaxia Eye Hospital Group Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Huaxia Eye Hospital Group Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Huaxia Eye Hospital Group Co. Ltd. A from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥6.02 Billion | +5.35% |
| 2023-12-31 | CN¥5.72 Billion | +11.45% |
| 2022-12-31 | CN¥5.13 Billion | +177.48% |
| 2021-12-31 | CN¥1.85 Billion | +27.37% |
| 2020-12-31 | CN¥1.45 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Huaxia Eye Hospital Group Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 303.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.39 Billion | 41.30% |
| Other Components | CN¥3.40 Billion | 58.70% |
| Total Equity | CN¥5.79 Billion | 100.00% |
Huaxia Eye Hospital Group Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Huaxia Eye Hospital Group Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Metro Investment Development Co Ltd
SHG:600683
|
$385.96 Million |
|
North Long Dragon New Materials Technology Co. Ltd. A
SHE:301357
|
$386.00 Million |
|
Furuno Electric Co., Ltd.
PINK:FNOEF
|
$386.02 Million |
|
Beijing Forever Technology Co Ltd
SHE:300365
|
$386.36 Million |
|
HMC Capital Ltd
AU:HMC
|
$385.64 Million |
|
Guangdong Insight Brand Marketing Group Co Ltd
SHE:300781
|
$385.41 Million |
|
FRoSTA AG
F:NLM
|
$385.30 Million |
|
Beijing Electronic Zone Investment and Development Group Co Ltd
SHG:600658
|
$385.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Huaxia Eye Hospital Group Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,655,272,645 to 5,794,409,773, a change of 139,137,128 (2.5%).
- Net income of 428,640,509 contributed positively to equity growth.
- Dividend payments of 92,114,666 reduced retained earnings.
- Other factors decreased equity by 197,388,714.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥428.64 Million | +7.4% |
| Dividends Paid | CN¥92.11 Million | -1.59% |
| Other Changes | CN¥-197.39 Million | -3.41% |
| Total Change | CN¥- | 2.46% |
Book Value vs Market Value Analysis
This analysis compares Huaxia Eye Hospital Group Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.55x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.31x to 2.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥1.89 | CN¥17.62 | x |
| 2021-12-31 | CN¥2.44 | CN¥17.62 | x |
| 2022-12-31 | CN¥6.09 | CN¥17.62 | x |
| 2023-12-31 | CN¥6.73 | CN¥17.62 | x |
| 2024-12-31 | CN¥6.90 | CN¥17.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Huaxia Eye Hospital Group Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.40%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.64%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 1.37x
- Recent ROE (7.40%) is below the historical average (15.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 23.57% | 13.30% | 0.91x | 1.95x | CN¥192.53 Million |
| 2021 | 24.83% | 14.85% | 0.95x | 1.76x | CN¥271.72 Million |
| 2022 | 10.04% | 15.89% | 0.48x | 1.32x | CN¥2.16 Million |
| 2023 | 11.78% | 16.59% | 0.54x | 1.30x | CN¥100.40 Million |
| 2024 | 7.40% | 10.64% | 0.51x | 1.37x | CN¥-150.80 Million |
Industry Comparison
This section compares Huaxia Eye Hospital Group Co. Ltd. A's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $2,886,733,282
- Average return on equity (ROE) among peers: 7.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | CN¥6.06 Billion | 23.57% | 0.35x | $385.79 Million |
| Xian International Medical Investment Co Ltd (000516) | $3.50 Billion | 5.76% | 0.59x | $1.03 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $347.62 Million | 6.68% | 0.24x | $2.93 Billion |
| Hengkang Medical Group Co Ltd (002219) | $414.18 Million | 15.93% | 0.24x | $692.82 Million |
| Aier Eye Hospital Group (300015) | $12.22 Billion | 19.01% | 0.79x | $5.88 Billion |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $1.88 Billion | -1.46% | 0.18x | $159.92 Million |
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | $2.12 Billion | -4.80% | 1.17x | $342.22 Million |
| Sanbo Hospital Management Group Ltd. A (301293) | $2.51 Billion | 3.12% | 0.25x | $1.52 Billion |
| Top Choice Medical Investment Co Inc (600763) | $100.20 Million | 13.53% | 0.09x | $1.69 Billion |